Here s Why Raptor Pharmaceuticals Corp #marketing #pharmaceuticals

Posted On Sep 8 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #pharmaceutical #industry #market #share

Posted On Aug 17 2017 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Here are 10 of the fastest growing health IT companies, according to Inc #pharmas

Posted On Aug 16 2017 by

#health it companies # Here are 10 of the fastest growing health IT companies, according to Inc. The interest in using health IT tools as a way to improve healthcare delivery and efficiency has produced many rapidly growing healthcare companies, many of which can trace their origins within one or two years of Obamacare s passage. These companies have reached a stage of their development to accelerate growth and that has coincided with a readiness by healthcare providers and payers to adopt or ramp up their technology. With a nod to the top healthcare company on Inc s 5,000 Fastest …


Portland Family Law Attorney #lawyer, #attorney, #law #firm, #law #office, #legal #advice, #family #law, #divorce, #child #support, #child #custody, #attorney, #name #here, #portland #attorney, #portland #lawyer, #law #firm #in #portland

Posted On Aug 14 2017 by

# Portland Family Will, Trust Probate Attorneys Family Law is not all about conflict resolution. Family Protection Planning is Life Planning for happy, healthy families. For 20 years much of our law practice has been devoted to protecting the financial health security of Portland Families. Wills, trusts and health care directives (living wills) are all family tools for proper protection of what you have and what you will earn over your lifetime. These legal tools permit you to control where your assets will go upon your death. It is a pleasure to help local Portland area residents with their all-important …


Sick of pharmaceutical ads? Here – s why they won – t go away #pharmaceutical #industry #research

Posted On Aug 9 2017 by

#pharmaceutical advertising # It seems like every other billboard and commercial in the U.S. is for a prescription drug. And yet consumers can t buy them without a doctor s approval. So why target consumers with these ads? Do we really have that much influence over physicians? Here s how the U.S. became one of the only countries in the world where pharmaceutical companies peddle drugs to ordinary people. Food and Drug Administration Loopholes The United States and New Zealand are the only countries in the world that allow direct-to-consumer advertising of pharmaceuticals. Most countries banned the practice in the …


Here s Why Raptor Pharmaceuticals Corp #pharma #iq

Posted On Aug 9 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #verona #pharma

Posted On Aug 9 2017 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #alliance #pharma

Posted On Aug 2 2017 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Here are 10 of the fastest growing health IT companies, according to Inc #health #industry #news

Posted On Aug 2 2017 by

#health it companies # Here are 10 of the fastest growing health IT companies, according to Inc. The interest in using health IT tools as a way to improve healthcare delivery and efficiency has produced many rapidly growing healthcare companies, many of which can trace their origins within one or two years of Obamacare s passage. These companies have reached a stage of their development to accelerate growth and that has coincided with a readiness by healthcare providers and payers to adopt or ramp up their technology. With a nod to the top healthcare company on Inc s 5,000 Fastest …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #biggest #pharmaceutical #companies

Posted On Jul 25 2017 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …